The changing therapeutic landscape for urticaria, angioedema, and anaphylaxis is evidenced by emerging treatments reported at ...

Remibrutinib results in significant improvement in composite measure of itching and hives after second-generation H1-antihistamine treatment.

Morgan Stanley backs Celldex Therapeutics for growth with barzolvolimab's market-leading potential in chronic urticaria. Read ...

Medical Twitter has found its new favourite resource — and it’s making life a lot easier for medical students. Abdul Muqtadir ...

Hanna Newnham, 27, from Brighton, first noticed symptoms of cold urticaria - hives that appear after cold temperature ...

The annual meeting of the American Academy of Dermatology was held from March 7 to 11 in Orlando, Florida, and attracted ...

Those who have bottles of Benadryl sitting around will need to make sure they're safe for children. According to the United ...

A new drug application for povorcitinib is expected to be filed in late 2025 to early 2026 to treat adult patients with ...